$1M DOD Grant Supports AS-202 for Sporadic ALS

$1M DOD Grant Supports AS-202 for Sporadic ALS

296110

$1M DOD Grant Supports AS-202 for Sporadic ALS

AccuraStem has been awarded a $1 million grant from the U.S. Department of Defense (DOD) to advance AS-202, a potentially disease-modifying therapy for sporadic amyotrophic lateral sclerosis (ALS), according to a press release. The candidate therapy is designed to increase the number of lysosomes — cell compartments in which unwanted molecules are broken down or digested — by lowering the levels of the PIKfyve kinase enzyme. Abnormal lysosome function is a common feature of neurodegenerative…

You must be logged in to read/download the full post.